Skip to main content
Industrial Research And Consultancy Centre
Patent
Implantable Cardio-Vascular Flow Streamliner
Abstract

The designed technology introduces an implantable Flow Streamliner to improve pulmonary blood flow circulation in patients who are required to undergo or have already undergone a Total Cavo-Pulmonary Connection (TCPC). This device helps manage blood flow from two major veins, the Inferior Vena Cava (IVC) and the Superior Vena Cava (SVC), into the pulmonary arteries. Function:

  • Splitting Blood Streams: The Flow Streamliner separates the blood from the IVC and SVC to prevent direct collision and streamline their flow. 
  • Distributing Blood: From the IVC: It ensures that blood carrying nutrients from the liver is evenly distributed to the Left Pulmonary Artery (LPA) and the Right Pulmonary Artery (RPA). From the SVC: It ensures that blood is distributed equally between the LPA and RPA.
Societal Impact

The implantable Flow Streamliner can improve the quality of life for patients with Total Cavo Pulmonary Connection (TCPC). By enhancing blood flow efficiency and distribution, it reduces the risk of complications and long-term health issues. This innovation not only lowers healthcare costs by minimizing the need for additional surgical interventions but also supports the natural growth and development of young patients.

Salient technical features and Advantages of the Technology
  • Quadrilateral Shape: Features a unique thin, pliable sheet made of biocompatible material with a quadrilateral shape tailored for TCPC junctions. 
  • Adaptive Curvilinear Bending: Bends curvilinearly based on blood flow rates, enhancing efficient blood stream regulation. 
  • Flow Splitting: Uniquely configured to split and guide blood streams from the IVC and SVC without causing shear or collision. 
  • Even Distribution: Ensures proportional distribution of blood from the IVC and SVC to the LPA and RPA. 
  • Supports Natural Growth: Allows for the natural growth of blood vessels and improves cardiovascular hemodynamics.


Technology readiness level

7

Current Status of Technology

The researchers have further worked on the ideation and currently working on the prototype. Current Status is as follows: 

  • The Implantable Cardio-Vascular Flow Streamliner, in Phase-II clinical trials. 
  • Progressing through final product design validation and prototype testing, it's on track for clinical implementation.
Relevant Industries

Medical Devices, Biomedical Engineering, Cardiovascular Surgery, Pediatric Cardiology, Healthcare Technology

Applications or Domain
  • Cardiovascular Surgery: Applied in cardiovascular surgical procedures for patients with Total Cavo Pulmonary Connection (TCPC) to enhance blood flow efficiency and distribution. 
  • Pediatric Cardiology: Used in pediatric cardiology to support the natural growth of blood vessels and improve long-term cardiovascular health in children undergoing TCPC.